Kaleido Biosciences (Kaleido Biosciences) EV-to-Revenue : -15.20 (As of Apr. 25, 2024)

Kaleido Biosciences EV-to-Revenue Chart

Kaleido Biosciences Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
EV-to-Revenue	Get a 7-Day Free Trial														310.35	214.58	215.81	231.98	77.01

Competitive Comparison of Kaleido Biosciences's EV-to-Revenue

For the Biotechnology subindustry, Kaleido Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kaleido Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kaleido Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kaleido Biosciences's EV-to-Revenue falls into.

Kaleido Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Kaleido Biosciences's EV-to-Revenue for today is calculated as:

Kaleido Biosciences's current Enterprise Value is $-16.78 Mil.
Kaleido Biosciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences  (OTCPK:KLDO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Kaleido Biosciences's PS Ratiofor today is calculated as:

Kaleido Biosciences's share price for today is $0.0001.
Kaleido Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kaleido Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaleido Biosciences (Kaleido Biosciences) Business Description